Clinical trials

  • ELACESTRANT for Early breast cancer | Estrogen receptor-positive breast cancer | HER2-negative breast cancer | Node-positive breast cancer
  • TAFASITAMAB for Diffuse large B-cell lymphoma (DLBCL)
  • TARLATAMAB for Extensive-stage small cell lung cancer|Small cell lung cancer
  • FURAZIDINE for Bacterial vaginosis
  • ALLOGENEIC FAECAL MICROBIOTA, POOLED for Non-alcoholic steatohepatitis
  • IFINATAMAB DERUXTECAN for Squamous non-small cell lung cancer (stage IV)
  • Clinical trial in Limbal stem cell deficiency
  • DISITAMAB VEDOTIN for Urothelial carcinoma
  • Fibrin for Critical limb ischemia
  • Amiloride hydrochloride, furosemide for ER-positive, HER2-negative breast cancer (stages I–II) | ER-positive, HER2-negative breast cancer (stages I–III)
  • PACLITAXEL ALBUMIN-BOUND for Metastatic non-small cell lung cancer
  • SONELOKIMAB for Psoriatic arthritis